Abstract
Purpose
A diuresis is a key part of acclimatisation to high altitude (HA). Arginine vasopressin (AVP) is a hormone involved in salt and water balance and may potentially have a role in the development of altitude illness. ProAVP (copeptin) is more stable than AVP and is assayed by a straightforward, automated method. We investigated the relationship of AVP to copeptin and the copeptin response to exercise and altitude illness in a large cohort during a field study at HA.
Methods
48 subjects took part in a 10-day trek at HA. Venous blood samples were taken at 3,833, 4,450 and 5,129 m post-trek (exercise) and the following day at rest. Daily recordings of symptoms of altitude illness, oxygen saturations and perceived exertion were carried out.
Results
AVP and copeptin levels increased with exercise and correlated closely (ρ 0.621 p < 0.001), this was strongest in the stressed state when AVP secretion was highest, at 5,129 m post-exercise (ρ 0.834 p < 0.001). On two-way ANOVA, both altitude (F = 3.5; p = 0.015) and exercise (F = 10.2; p = 0.002) influenced copeptin levels (interaction F = 2.2; p = 0.08). AVP levels were influenced by exercise (F = 14.4; p = 0.0002) but not altitude (F = 2.0; p = 0.12) with no overall group interactions (F = 1.92.6; p = 0.06). There was no association between copeptin or arginine vasopressin and altitude illness. Copeptin correlated with the Borg RPE score and was significantly higher in the group with a Borg score ≥15 (7.9 vs. 3.7 p < 0.001).
Conclusion
We have shown that arginine vasopressin and copeptin levels correlate and are suppressed below 5,129 m. Furthermore, we have demonstrated that exertion, rather than altitude illness or increasing osmolality, is the stimulus for increases in copeptin.
Similar content being viewed by others
Abbreviations
- AMS:
-
Acute mountain sickness
- AVP:
-
Arginine vasopressin
- HA:
-
High altitude
- HACE:
-
High altitude cerebral edema
- HAPE:
-
High altitude pulmonary edema
- LLS:
-
Lake Louise Score
- RPE:
-
Rating of perceived exertion
References
Anand IS et al (1993) Body fluid compartments, renal blood flow, and hormones at 6,000 m in normal subjects. J Appl Physiol (1993) 74:1234–1239
Balanescu S, Kopp P, Gaskill MB, Morgenthaler NG, Schindler C, Rutishauser J (2011) Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States. J Clin Endocrinol Metab 96:1046–1052
Barry PW, Pollard AJ (2003) Altitude illness. BMJ 326:915–919
Bartsch P et al (1991) Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness. J Appl Physiol 71:136–143
Bestle MH, Olsen NV, Poulsen TD, Roach R, Fogh-Andersen N, Bie P (2002) Prolonged hypobaric hypoxemia attenuates vasopressin secretion and renal response to osmostimulation in men. J Appl Physiol 92:1911–1922
Bhandari SS, Loke I, Davies JE, Squire IB, Struck J, Ng LL (2009) Gender and renal function influence plasma levels of copeptin in healthy individuals. Clin Sci (Lond) 116:257–263
Blume FD, Boyer SJ, Braverman LE, Cohen A, Dirkse J, Mordes JP (1984) Impaired osmoregulation at high altitude. Studies on Mt Everest. JAMA 252:524–526
Borg G (1970) Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 2:92–98
Bouissou P, Fiet J, Guezennec CY, Pesquies PC (1988) Plasma adrenocorticotrophin and cortisol responses to acute hypoxia at rest and during exercise. Eur J Appl Physiol Occup Physiol 57:110–113
Burd J, Weightman DR, Spruce BA, Baylis PH (1984) A solid phase radioimmunoassay for human plasma arginine vasopressin. Clin Chim Acta 136:251–256
Graham I et al (2007) European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 14(2):S1–S113
Hew-Butler T, Hoffman MD, Stuempfle KJ, Rogers IR, Morgenthaler NG, Verbalis JG (2011) Changes in copeptin and bioactive vasopressin in runners with and without hyponatremia. Clin J Sport Med 21:211–217
Jochberger S et al (2006) Copeptin and arginine vasopressin concentrations in critically ill patients. J Clin Endocrinol Metab 91:4381–4386
Jochberger S et al (2009) The vasopressin and copeptin response in patients with vasodilatory shock after cardiac surgery: a prospective, controlled study. Intensive Care Med 35:489–497
Knoepfelmacher M, Pradal MJ, Dio RD, Salgado LR, Semer M, Wajchenberg BL, Liberman B (1997) Resistance to vasopressin action on the kidney in patients with Cushing’s disease. Eur J Endocrinol 137:162–166
Loeppky JA, Icenogle MV, Maes D, Riboni K, Hinghofer-Szalkay H, Roach RC (2005a) Early fluid retention and severe acute mountain sickness. J Appl Physiol 98:591–597
Loeppky JA et al (2005b) Role of hypobaria in fluid balance response to hypoxia. High Alt Med Biol 6:60–71
Maggiorini M, Buhler B, Walter M, Oelz O (1990) Prevalence of acute mountain sickness in the Swiss Alps. BMJ 301:853–855
Maresh CM et al (2004) Effects of high altitude and water deprivation on arginine vasopressin release in men. Am J Physiol Endocrinol Metab 286:E20–E24
Morgenthaler NG, Struck J, Alonso C, Bergmann A (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52:112–119
Morgenthaler NG, Struck J, Jochberger S, Dunser MW (2008) Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 19:43–49
Okazaki S, Tamura Y, Hatano T, Matsui N (1984) Hormonal disturbances of fluid-electrolyte metabolism under altitude exposure in man. Aviat Space Environ Med 55:200–205
Porchet M, Contat H, Waeber B, Nussberger J, Brunner HR (1984) Response of plasma arginine vasopressin levels to rapid changes in altitude. Clin Physiol 4:435–438
Ramirez G, Hammmond M, Agosti S, Bittle P, Dietz J, Colice G (1992) Effects of hypoxiaemia at sea level and high altitude on sodium excretion and hormonal levels. Aviat Space Environ Med 63:891–898
Roach RC, Bartsch P, Oelz O, Hackett PH, Committee LLASC (1993) The Lake Louise acute mountain sickness scoring system. In: Sutton JRHC, Coates G (eds) Hypoxia and molecular medicine. Charles S, Houston, pp 272–274
Westermann I et al (2007) Endogenous vasopressin and copeptin response in multiple trauma patients. Shock 28:644–649
Woods DR et al (2012) The cortisol response to hypobaric hypoxia at rest and post-exercise. Horm Metab Res 44:302–305
Zaccaria M, Rocco S, Noventa D, Varnier M, Opocher G (1998) Sodium regulating hormones at high altitude: basal and post-exercise levels. J Clin Endocrinol Metab 83:570–574
Acknowledgments
We are indebted to the study participants for carrying out the study in often difficult and trying circumstances. The expert assistance of Mrs Margaret Brodie of the Royal Victoria Infirmary, Newcastle, UK, in supervising the AVP and copeptin assays and Elizabeth Wiredu of Data Solution Services in providing statistical advice is gratefully acknowledged. The Drummond Foundation, Surgeon General’s Research Study Group, Joint Medical Command and Joint Service Expedition Trust for funding towards the research costs.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Carsten Lundby.
Rights and permissions
About this article
Cite this article
Mellor, A.J., Boos, C.J., Ball, S. et al. Copeptin and arginine vasopressin at high altitude: relationship to plasma osmolality and perceived exertion. Eur J Appl Physiol 115, 91–98 (2015). https://doi.org/10.1007/s00421-014-2994-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00421-014-2994-7